CZ418597A3 - 1,6-disubstituované izochromany pro léčbu bolestí hlavy při migréně - Google Patents

1,6-disubstituované izochromany pro léčbu bolestí hlavy při migréně Download PDF

Info

Publication number
CZ418597A3
CZ418597A3 CZ974185A CZ418597A CZ418597A3 CZ 418597 A3 CZ418597 A3 CZ 418597A3 CZ 974185 A CZ974185 A CZ 974185A CZ 418597 A CZ418597 A CZ 418597A CZ 418597 A3 CZ418597 A3 CZ 418597A3
Authority
CZ
Czechia
Prior art keywords
defined above
ethyl
isochroman
alkyl
piperazinyl
Prior art date
Application number
CZ974185A
Other languages
Czech (cs)
English (en)
Inventor
Michael D. Ennis
Ruth E. Tenbrink
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of CZ418597A3 publication Critical patent/CZ418597A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ974185A 1995-06-30 1996-06-07 1,6-disubstituované izochromany pro léčbu bolestí hlavy při migréně CZ418597A3 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US1123496P 1996-02-06 1996-02-06

Publications (1)

Publication Number Publication Date
CZ418597A3 true CZ418597A3 (cs) 1998-06-17

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ974185A CZ418597A3 (cs) 1995-06-30 1996-06-07 1,6-disubstituované izochromany pro léčbu bolestí hlavy při migréně

Country Status (12)

Country Link
EP (1) EP0836599A1 (no)
JP (1) JPH11509532A (no)
AU (1) AU6252296A (no)
BR (1) BR9609631A (no)
CA (1) CA2225282A1 (no)
CZ (1) CZ418597A3 (no)
FI (1) FI974640A (no)
MX (1) MX9710260A (no)
NO (1) NO976112L (no)
PL (1) PL324319A1 (no)
SK (1) SK164297A3 (no)
WO (1) WO1997002259A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
AU2005238179B2 (en) 2004-05-05 2010-08-26 F. Hoffmann-La Roche Ag Arylsulfonyl benzodioxanes useful for modulating the 5-HT6 receptor, the 5-HT2A receptor or both
RU2389723C2 (ru) 2004-12-21 2010-05-20 Ф. Хоффманн-Ля Рош Аг Производные тетралина и индана и их применения
CA2592001A1 (en) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Chroman derivatives and their use as 5-ht receptor ligands
RU2396255C2 (ru) 2004-12-21 2010-08-10 Ф. Хоффманн-Ля Рош Аг Производные тетралина и индана и их применения
ES2314749T3 (es) 2004-12-21 2009-03-16 F. Hoffmann-La Roche Ag Derivados de tetralina y de indano y usos de los mismos como antagonistas de 5-ht.
CA2591810A1 (en) 2004-12-21 2006-06-29 F.Hoffmann-La Roche Ag Chroman derivatives and uses thereof in the treatment of cns disorders
ES2359735T3 (es) 2005-11-03 2011-05-26 F. Hoffmann-La Roche Ag Arilsulfonilcromanos como inhibidores de 5-ht6.
BRPI0713742A2 (pt) 2006-06-20 2013-02-13 Hoffmann La Roche derivados de arilsulfonila naftaleno e usos destes
AU2007263084A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN101472883A (zh) 2006-06-20 2009-07-01 弗·哈夫曼-拉罗切有限公司 芳基磺酰氨基四氢萘衍生物以及其应用
US20110313197A1 (en) * 2009-03-05 2011-12-22 Sumitomo Chemical Company, Limited Method for producing halogen-substituted benzene dimethanol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
NZ277373A (en) * 1993-12-28 1998-07-28 Upjohn Co Iso(thio)chroman-1-ylethylpiperazine and -piperidine derivatives (analogues)

Also Published As

Publication number Publication date
FI974640A0 (fi) 1997-12-30
MX9710260A (es) 1998-03-29
BR9609631A (pt) 1999-03-02
FI974640A (fi) 1997-12-30
CA2225282A1 (en) 1997-01-23
NO976112L (no) 1998-03-02
EP0836599A1 (en) 1998-04-22
AU6252296A (en) 1997-02-05
JPH11509532A (ja) 1999-08-24
SK164297A3 (en) 1998-09-09
PL324319A1 (en) 1998-05-25
WO1997002259A1 (en) 1997-01-23
NO976112D0 (no) 1997-12-29

Similar Documents

Publication Publication Date Title
AU2013254657B2 (en) Novel compounds
AU701452B2 (en) Benzylpiperidines and piperazines as muscarinic antagonists
AU701420B2 (en) Novel piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them
KR101025358B1 (ko) 히스타민-3 수용체 길항제
TW536537B (en) Benzoxazine antimicrobial agents
CZ418597A3 (cs) 1,6-disubstituované izochromany pro léčbu bolestí hlavy při migréně
CA2748251A1 (en) Bicyclic heterocyclic compound for use as a sensory neuron specific sodium channel inhibitor
JPWO2005037269A1 (ja) 新規ピペリジン誘導体
HU211336A9 (en) Heterocyclic derivatives
AU684874B2 (en) Heterocyclic compounds for the treatment of cns and cardiovascular disorders
JP2001525406A (ja) 新規な化合物
EP1940823A2 (fr) Dérivés de la 1-amino-phtalazine substituee, leur préparation et leur application en thérapeutique
JP2015524481A (ja) (s)−3−(4−((4−(モルホリノメチル)ベンジル)オキシ)−1−オキソイソインドリン−2−イル)ピペリジン−2,6−ジオン及びその医薬として許容し得る形態の製造プロセス
JP2006527769A (ja) Cb1モジュレーターとしての2,3位置換5,6−ジアリール−ピラジン誘導体
AU2021410119A1 (en) Tetrahydroquinoline derivative and medicinal use thereof
JP3035356B2 (ja) ピロリジニルヒドロキサム酸化合物及びその製造方法
HU225747B1 (en) New benzenesulphonamide compounds, their preparation thereof and pharmaceutical compositions containing them
US20040034036A1 (en) N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
KR20150065190A (ko) 피라진 유도체
OA11235A (en) Quatenary ammonium compounds as tachykinin antagonists
MXPA04012345A (es) Derivados de pirimidina 2,5-substituida como antagonistas ix del receptor ccr-3.
AU707950B2 (en) Heterocyclic compounds for treating myocardial ischemia
JPH06306025A (ja) ジアリールアルカン誘導体
KR19990028550A (ko) 편두통 치료용의 1,6-이치환된 이소크로만
KR940009533B1 (ko) 헥사하이드로디벤조디옥산에서 유도된 암모늄염의 제조방법

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic